This report is being filed on an international product, architect total psa, list 7k70, that has a similar product distributed in the us, total psa, list number 6c06.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient information: no specific patient information was provided.
|
Review of complaint activity did not identify any adverse or non-statistical trends for the architect total psa assay.Using worldwide field data the historical performance of the assay was reviewed.The patient median result for each reagent lot was analyzed and found to be within 2 standard deviations of the established baseline, confirming no systemic issue for the assay.Manufacturing documentation for the assay did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.Based on the available information, no systemic issue or deficiency of the architect total psa assay was identified.
|